Pending Revision Of ISO Device Clinical Research Standard Ups Safety Focus
This article was originally published in The Gray Sheet
Executive SummaryThe International Organization for Standardization (ISO) has developed a final draft revision of its standard for medical device clinical research, with an eye toward boosting trial quality and safety monitoring
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.